Key to immune system's memory revealed

December 19, 2017, Monash University
This is Dr Jasmine Li, Professor Stephen J Turner, Dr Moshe Olshansky, Dr Brendan Russ. Credit: Monash University

Monash University's Biomedicine Discovery Institute scientists have defined a novel molecular 'blueprint' that plays a pivotal part in the immune system's ability to fight disease by 'remembering' infections. Understanding the fine detail of immunological memory potentially opens ways to improve, and to create new vaccines, and to hone treatments that use the immune system to fight disease including cancer.

During a response to the immune system's B and T create , allowing it to develop immunity to future infections and also to gain protection through vaccines, which serve to mimic the sort of immunity induced by the virus or bacteria the is trying to prevent.

The study, led by Professor Stephen Turner, used the influenza virus to investigate how cytotoxic or killer T cells - the 'hit men' for fighting infection - are genetically wired to behave.

"What we found is there's a specific sort of wiring that seems to characterise this type of - it's like an electrical circuit," Professor Turner said.

"We were able to identify specific 'switches' that are used in parts of the genome that actually give T cells their function," he said. "This means we can actually look at ways of going in and rewiring these things ourselves using novel vaccine type strategies," he said.

The gene regulatory mechanisms that control the changes that occur in T cells during infection were previously largely unknown.

The study, which used cutting-edge gene sequencing techniques in animal models of influenza, was published today in the prestigious journal Cell Reports.

The 'blueprint' developed by the team could serve as a benchmark for research, and potentially be used to hone and personalise therapies, Professor Turner said.

"We can design very rational and strategic therapies such as vaccines that target particular pathogens. It might be in the context of HIV, flu or malaria, particularly when you have complex viruses that we don't have vaccines for."

The same mechanisms engaging T cells that are used to fight infection are used to fight cancer and in , he said. The study may also have implications for auto-immune diseases such as multiple sclerosis, type 1 diabetes or coeliac disease, when T cells go awry causing the immune system to attack itself.

Professor Turner and his research group in the Department of Microbiology, which he heads, are furthering the research using and are finding that many of the results are translating well.

Explore further: Understanding T cell activation could lead to new vaccines

Related Stories

Understanding T cell activation could lead to new vaccines

May 30, 2017
Scientists could be one step closer to developing vaccines against viruses such as Zika, West Nile or HIV, according to Penn State College of Medicine researchers.

Scientists find potential mechanism for deadly, sepsis-induced secondary infection

September 14, 2017
In mice, an infection-induced condition known as sepsis may increase the risk of life-threatening secondary infection by preventing recruitment of infection-fighting cells to the skin, according to new research published ...

'Bystander' chronic infections thwart development of immune cell memory

May 15, 2014
Studies of vaccine programs in the developing world have revealed that individuals with chronic infections such as malaria and hepatitis tend to be less likely to develop the fullest possible immunity benefits from vaccines ...

A vaccine candidate that supports immunity where it matters most

October 29, 2015
Almost all infections make us sick by getting past our first line of defense - the sticky mucous surfaces that line our mouths, our eyes, our lungs and our guts. Once through, it's up to the immune cells that reside in our ...

Engineered virus has artificial amino acid allowing it to serve as a vaccine

December 2, 2016
(Medical Xpress)—A team of researchers at Peking University has developed a new type of vaccine that they claim may allow for a new approach to generating live virus vaccines which could conceivably be adapted to any type ...

A new role for an old immune cell may lead to novel therapies for infection and cancer

March 1, 2017
A new study has identified a previously undescribed role for a type of unconventional T cell with the potential to be used in the development of new therapies for infection and cancer.

Recommended for you

Improving vaccines for the elderly by blocking inflammation

January 22, 2018
By identifying why skin immunity declines in old age, a UCL-led research team has found that an anti-inflammatory pill could help make vaccines more effective for elderly people.

Novel genomic tools provide new insight into human immune system

January 19, 2018
When the body is under attack from pathogens, the immune system marshals a diverse collection of immune cells to work together in a tightly orchestrated process and defend the host against the intruders. For many decades, ...

First vaccine developed against grass pollen allergy

January 18, 2018
Around 400 million people worldwide suffer in some form or other from a grass pollen allergy (rhinitis), with the usual symptoms of runny nose, cough and severe breathing problems. In collaboration with the Viennese firm ...

Genomics reveals key macrophages' involvement in systemic sclerosis

January 18, 2018
A new international study has made an important discovery about the key role of macrophages, a type of immune cell, in systemic sclerosis (SSc), a chronic autoimmune disease which currently has no cure.

Researchers discover key driver of atopic dermatitis

January 17, 2018
Severe eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that is driven by an allergic reaction. In their latest study, researchers at La Jolla Institute reveal an important player that promotes ...

Who might benefit from immunotherapy? New study suggests possible marker

January 16, 2018
While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.